Ignite Creation Date:
2024-07-17 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06499870
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-07-08
Brief Title:
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer OPTIMAL Trial
Sponsor:
Northwestern University
Organization:
Northwestern University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Prostate Adenocarcinoma |
Keywords: